Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YM150 for VTE prevention in hip replacement surgery
NCT00902928Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Apr 2009
- Primary completion
- Jun 2010
- Countries
- 28
01
Overview
A Phase 3 trial of darexaban in venous thromboembolism (VTE), sponsored by Astellas Pharma. Started Apr 2009; status: completed.
02
Drugs
darexaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT00902928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00902928.